Anemoside A3CAS# 129724-84-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 129724-84-1 | SDF | Download SDF |
| PubChem ID | 11721847 | Appearance | White powder |
| Formula | C41H66O12 | M.Wt | 750.96 |
| Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
| Synonyms | Anemoside A3 | ||
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (1R,3aS,5aR,5bR,7aR,8R,9S,11aR,11bR,13aR,13bR)-9-[(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid | ||
| SMILES | CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C5CCC6C7C(CCC7(CCC6(C5(CCC4C3(C)CO)C)C)C(=O)O)C(=C)C)C)O)O)O)O)O | ||
| Standard InChIKey | ISNDTNDJSXYNKT-DVIRKNLQSA-N | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Anemoside A3 is an attractive candidate for further development as a cognitive enhancer capable of alleviating memory dysfunctions associated with aging and neurodegenerative diseases. Anemoside A3 also produces relaxation in rat renal arteries through multiple mechanisms. |
| Targets | NMDAR | Calcium Channel | Potassium Channel |
| In vitro | Anemoside A3 Enhances Cognition through the Regulation of Synaptic Function and Neuroprotection.[Pubmed: 25649278]Neuropsychopharmacology. 2015 Jul;40(8):1877-87.Compounds that have the ability to both strengthen synaptic function and facilitate neuroprotection are valuable cognitive enhancers that may improve health and quality of life, as well as retard age-related cognitive deterioration. Medicinal plants are an abundant source of potential cognitive enhancers. Pulsatilloside A and anemoside A3 protect PC12 cells from apoptosis induced by sodium cyanide and glucose deprivation.[Pubmed: 12624827]Planta Med. 2003 Feb;69(2):171-4.
|
| Kinase Assay | Anemoside A3-induced relaxation in rat renal arteries: role of endothelium and Ca2+ channel inhibition.[Pubmed: 20506075]Planta Med. 2010 Nov;76(16):1814-9.Anemoside A3, a lupane-type triterpenoid saponin, exists in the roots of Pulsatilla chinensis, but its pharmacological properties are largely unknown. |
Anemoside A3 Dilution Calculator
Anemoside A3 Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.3316 mL | 6.6581 mL | 13.3163 mL | 26.6326 mL | 33.2907 mL |
| 5 mM | 0.2663 mL | 1.3316 mL | 2.6633 mL | 5.3265 mL | 6.6581 mL |
| 10 mM | 0.1332 mL | 0.6658 mL | 1.3316 mL | 2.6633 mL | 3.3291 mL |
| 50 mM | 0.0266 mL | 0.1332 mL | 0.2663 mL | 0.5327 mL | 0.6658 mL |
| 100 mM | 0.0133 mL | 0.0666 mL | 0.1332 mL | 0.2663 mL | 0.3329 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Pulchinenoside A is a natural triterpenoid saponin that enhances synaptic plasticity in the adult mouse hippocampus and facilitates spatial memory in adult mice. In vitro: Additions of pulsatilloside A and anemoside A3, at dosages ranging from 0.1, 1 and 10 μg/ml, protected PC12 cells from apoptosis. [1] In vivo:AA3 also acts as a non-competitive NMDA receptor (NMDAR) modulator with a neuroprotective capacity against ischemic brain injury and overexcitation in rats. [2] Anemoside A3 produces relaxation in rat renal arteries through multiple mechanisms. [3]
References:
[1]. Ip FC et al. Anemoside A3 Enhances Cognition through the Regulation of Synaptic Function and Neuroprotection. Neuropsychopharmacology. 2015 Jul;40(8):1877-87.
[2]. Zhang DM et al. Anemoside A3-induced relaxation in rat renal arteries: role of endothelium and Ca2+ channel inhibition. Planta Med. 2010 Nov;76(16):1814-9.
[3]. Gao XD et al. Pulsatilloside A and anemoside A3 protect PC12 cells from apoptosis induced by sodium cyanide and glucose deprivation. Planta Med. 2003 Feb;69(2):171-4.
- 3-Hydroxylanost-9(11)-24-dien-26-oic acid
Catalog No.:BCN1586
CAS No.:129724-83-0
- 2',4'-Dihydroxy-3',6'-dimethoxychalcone
Catalog No.:BCN6158
CAS No.:129724-43-2
- Aripiprazole
Catalog No.:BCC5034
CAS No.:129722-12-9
- Dofequidar
Catalog No.:BCC4176
CAS No.:129716-58-1
- ZD 7114 hydrochloride
Catalog No.:BCC6852
CAS No.:129689-28-7
- 3,4-Dihydroxybisabola-1,10-diene
Catalog No.:BCN7326
CAS No.:129673-87-6
- 3-Hydroxybisabola-1,10-dien-9-one
Catalog No.:BCN7325
CAS No.:129673-86-5
- GR 82334
Catalog No.:BCC5802
CAS No.:129623-01-4
- Nevirapine
Catalog No.:BCC3820
CAS No.:129618-40-2
- Satraplatin
Catalog No.:BCC5356
CAS No.:129580-63-8
- Goniopypyrone
Catalog No.:BCN3957
CAS No.:129578-07-0
- Tolfenpyrad
Catalog No.:BCC8069
CAS No.:129558-76-5
- Anemoside B4
Catalog No.:BCN1276
CAS No.:129741-57-7
- ODM-201
Catalog No.:BCC3796
CAS No.:1297538-32-9
- MC 976
Catalog No.:BCC1734
CAS No.:129831-99-8
- Amicarbazone
Catalog No.:BCC5464
CAS No.:129909-90-6
- Dapoxetine HCl
Catalog No.:BCC5064
CAS No.:129938-20-1
- Iloperidone hydrochloride
Catalog No.:BCC4212
CAS No.:1299470-39-5
- Senecionine
Catalog No.:BCN2129
CAS No.:130-01-8
- 1,4-Naphthoquinone
Catalog No.:BCN8420
CAS No.:130-15-4
- Thioridazine HCl
Catalog No.:BCC3869
CAS No.:130-61-0
- Protopine
Catalog No.:BCN6165
CAS No.:130-86-9
- Quinine HCl
Catalog No.:BCN2262
CAS No.:130-89-2
- Quinine
Catalog No.:BCN2341
CAS No.:130-95-0
Pulsatilloside A and anemoside A3 protect PC12 cells from apoptosis induced by sodium cyanide and glucose deprivation.[Pubmed:12624827]
Planta Med. 2003 Feb;69(2):171-4.
Using sodium cyanide (NaCN) and glucose deprivation induced cell injury in PC12 as an injury model, we investigated the protective effects of pulsatilloside A and anemoside A 3 on neurons. The results showed that PC12 cells under the NaCN-injury and glucose deprivation would undergo apoptosis. Additions of pulsatilloside A and anemoside A 3, at dosages ranging from 0.1, 1 and 10 microg/ml, protected PC12 cells from apoptosis determined by MTT, LDH release analysis, and flow cytometry measurement.
Anemoside A3 Enhances Cognition through the Regulation of Synaptic Function and Neuroprotection.[Pubmed:25649278]
Neuropsychopharmacology. 2015 Jul;40(8):1877-87.
Compounds that have the ability to both strengthen synaptic function and facilitate neuroprotection are valuable cognitive enhancers that may improve health and quality of life, as well as retard age-related cognitive deterioration. Medicinal plants are an abundant source of potential cognitive enhancers. Here we report that Anemoside A3 (AA3) isolated from Pulsatilla chinensis modulates synaptic connectivity in circuits central to memory enhancement. AA3 specifically modulates the function of AMPA-type glutamate receptors (AMPARs) by increasing serine phosphorylation within the GluA1 subunit, which is a modification required for the trafficking of GluA1-containing AMPARs to synapses. Furthermore, AA3 administration activates several synaptic signaling molecules and increases protein expressions of the neurotrophin brain-derived neurotrophic factor and monoamine neurotransmitters in the mouse hippocampus. In addition to acting through AMPARs, AA3 also acts as a non-competitive NMDA receptor (NMDAR) modulator with a neuroprotective capacity against ischemic brain injury and overexcitation in rats. These findings collectively suggest that AA3 possesses a unique ability to modulate the functions of both AMPARs and NMDARs. Concordantly, behavioral studies indicate that AA3 not only facilitates hippocampal long-term potentiation but also enhances spatial reference memory formation in mice. These multifaceted roles suggest that AA3 is an attractive candidate for further development as a cognitive enhancer capable of alleviating memory dysfunctions associated with aging and neurodegenerative diseases.
Anemoside A3-induced relaxation in rat renal arteries: role of endothelium and Ca2+ channel inhibition.[Pubmed:20506075]
Planta Med. 2010 Nov;76(16):1814-9.
Anemoside A(3), a lupane-type triterpenoid saponin, exists in the roots of Pulsatilla chinensis, but its pharmacological properties are largely unknown. The present study aimed to investigate the mechanisms underlying anemoside A(3)-induced relaxation in rat renal arteries. Changes of isometric force were determined on arteries with a myograph. Anemoside A(3) caused concentration-dependent relaxation in precontracted aortas, mesenteric, left coronary, and renal arteries. Removal of endothelium or treatment with charybdotoxin plus apamin slightly but significantly attenuated the relaxation in renal arteries. TEA(+) inhibited the relaxation caused by anemoside A(3) in renal arteries with and without endothelium while glibenclamide, BaCl(2), or capsaicin had no effect on it. Anemoside A(3) produced less relaxation in rings contracted by 60 mM KCl compared with rings contracted by receptor-dependent constrictors. It further inhibited contractions induced by Ca(2+) influx through nifedipine-sensitive voltage-gated Ca(2+) channels, nifedipine-insensitive receptor-operated Ca(2+) channels, and by intracellular Ca(2+) release. Pretreatment with nifedipine attenuated anemoside A(3)-induced relaxation. Taken together, the present results indicate that anemoside A(3) produces relaxation in rat renal arteries through multiple mechanisms. The release of CTX/apamin-sensitive endothelium-derived hyperpolarizing factor, stimulation of TEA(+)-sensitive K(+) channel, and inhibition of Ca(2+) influx jointly contribute to the relaxation.
